Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY:ASX)

10.33 -0.26 (-2.46%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ASE Technology Holding Co., Ltd. American Depositary Shares (each representing

< Previous 1 2 3 4 5 6 Next >
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE Technology Holding Co., Ltd Receives Industry Leadership Recognition on the Dow Jones Sustainability Indices for the Eighth Year in a Row
From ASE Technology Holding Co., Ltd.
Via Business Wire
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Brookfield Acknowledges Result of the Origin Energy Shareholder Vote
From Brookfield Renewable Partners L.P.
Via GlobeNewswire
Terra Uranium to Present at the OTC Clean Energy and Precious Metals Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire
Deep Yellow Webcast Live at VirtualInvestorConferences.com
The Company is pleased to invite individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Clean Energy and Precious Metals Virtual Investor Conference Agenda Announced for December 4th- December 6th, 2023
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE launches its Integrated Design EcosystemTM to enable silicon package design efficiencies that reduce cycle time by half
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Metals & Mining Virtual Investor Conference Agenda Announced for October 3rd- October 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Fortuna completes acquisition of Chesser Resources, strengthening its presence in West Africa
From Fortuna Silver Mines Inc.
Via GlobeNewswire
5 NYSE-Listed Emerging Market Stocks For Income Investors
Emerging markets could be spotlighted in 2024 due to outsized growth; here are 5 emerging market stocks that pay dividends and trade on US exchanges 
Via MarketBeat
Topics Artificial Intelligence
iGaming, Gaming and Entertainment Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Element 25 Limited to Present at the Clean Energy Metals Virtual Investor Conference August 24th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
New Patent Covers Over 150 Novel Compounds 
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Presentations Highlight New Data on Diagnostic Accuracy and Novel Biomarkers of Disease Severity in Multiple System Atrophy 
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Elevate Uranium Ltd to Present at the Clean Energy Metals Virtual Investor Conference August 24th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2022
From ASE Technology Holding Co., Ltd.
Via Business Wire
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Appendix 4C – Q4 FY23 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Pushpay Expands Giving Options, Announces Free Stock Donations with Engiven
Pushpay’s innovation in digital giving continues with new stock giving for churches 
From Pushpay
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.